Mithra logo.jpg
Information on the total number of voting rights (denominator)
21 sept. 2023 11h55 HE | Mithra Pharmaceuticals
Information on the total number of voting rights (denominator) Liege, Belgium, 21 September 2023 – 5:45 pm CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, today...
Mithra logo.jpg
Notice of Adjustment of the Conversion Price of Mithra's EUR 125,000,000 Senior Unsecured Convertible Bonds due 2025
12 sept. 2023 11h45 HE | Mithra Pharmaceuticals
Notice of Adjustment of the Conversion Price of Mithra's EUR 125,000,000 Senior Unsecured Convertible Bonds due 2025 (ISIN: BE6325746855) Liege, Belgium, 12 September 2023 – 5:45 pm CEST – Mithra...
Mithra logo.jpg
Publication of a Transparency Notification Received from Armistice Capital, LLC
12 sept. 2023 11h45 HE | Mithra Pharmaceuticals
Publication of a Transparency Notification Received from Armistice Capital, LLC Liege, Belgium, 12 September 2023 – 5:45pm CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s...
Mithra logo.jpg
Letter to Shareholders and Corporate Update
11 sept. 2023 01h30 HE | Mithra Pharmaceuticals
Letter to Shareholders and Corporate Update Liege, Belgium, 11 September 2023 – 7:30 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, (the “Company” or “Mithra”),...
Mithra logo.jpg
Mithra completes EUR 20 million private placement in equity. Update of total number of voting rights (denominator)
28 août 2023 11h45 HE | Mithra Pharmaceuticals
THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE PROHIBITED...
Mithra logo.jpg
Mithra prices private placement to raise EUR 20 million in equity
24 août 2023 01h33 HE | Mithra Pharmaceuticals
THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE PROHIBITED...
Mithra logo.jpg
Mithra and Gedeon Richter Sign Supply Agreement for Production of API for Estelle® and Donesta®
08 août 2023 01h30 HE | Mithra Pharmaceuticals
Mithra and Gedeon Richter Sign Supply Agreement for Production of API for Estelle® and Donesta® Gedeon Richter will manufacture and supply Estetrol (E4) for production of Estelle®,...
Mithra logo.jpg
Mithra Receives EUR 1.25 Million Milestone Payment from Fuji Pharma under Estelle® Licensing Agreement
03 août 2023 01h30 HE | Mithra Pharmaceuticals
Mithra Receives EUR 1.25 Million Milestone Payment from Fuji Pharma under Estelle® Licensing Agreement Relates to completion of the interim clinical study reports of Phase 3 trials in patients...
Mithra logo.jpg
Mithra and Searchlight Pharma Announce Donesta® Licensing Agreement for Canada
31 juil. 2023 01h30 HE | Mithra Pharmaceuticals
   Mithra and Searchlight Pharma Announce Donesta® Licensing Agreement for Canada Mithra to receive up to €17.05 million in licensing fees and regulatory and sales milestones, along with tiered...
Mithra logo.jpg
Mithra and Searchlight Pharma Announce Donesta® Licensing Agreement for Canada
31 juil. 2023 01h30 HE | Mithra Pharmaceuticals
   Mithra and Searchlight Pharma Announce Donesta® Licensing Agreement for Canada Mithra to receive up to €17.05 million in licensing fees and regulatory and sales milestones, along with tiered...